Literature DB >> 2410534

Antigen valence determines the binding of nominal antigen to cytolytic T cell clones.

R F Siliciano, R M Colello, A D Keegan, R Z Dintzis, H M Dintzis, H S Shin.   

Abstract

We have shown that cytotoxic T cell clones specific for the nominal antigen FL will bind high molecular weight (600,000 to 2,000,000) polyacrylamide and Ficoll polymers conjugated with 200-600 FL groups per molecule. Low molecular weight polymers (40,000) with the same epitope density did not give stable binding. A high molecular weight polymer with a lower epitope density also failed to bind. Taken together, these results suggest that a substantial degree of multivalence is a necessary factor in the stable binding of nominal antigen to T cell clones.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410534      PMCID: PMC2187759          DOI: 10.1084/jem.162.2.768

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Antibody affinity. 3. The role of multivalance.

Authors:  C L Hornick; F Karuch
Journal:  Immunochemistry       Date:  1972-03

2.  The influence of polyvalency on the binding properties of antibodies.

Authors:  D M Crothers; H Metzger
Journal:  Immunochemistry       Date:  1972-03

3.  Studies on the immunogenicity and tolerogenicity of T-independent antigens.

Authors:  R Z Dintzis; M H Middleton; H M Dintzis
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

4.  T-cell hybridoma specific for a cytochrome c peptide: specific antigen binding and interleukin 2 production.

Authors:  S Carel; C Bron; G Corradin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

5.  The diversity of T cell receptors specific for self MHC gene products.

Authors:  R F Siliciano; R Brookmeyer; H S Shin
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

6.  Molecular determinants of immunogenicity: the immunon model of immune response.

Authors:  H M Dintzis; R Z Dintzis; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

7.  Binding of antigen in the absence of histocompatibility proteins by arsonate-reactive T-cell clones.

Authors:  A Rao; W W Ko; S J Faas; H Cantor
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

8.  Thymus-independent antigens: the preparation of covalent, hapten-ficoll conjugates.

Authors:  J K Inman
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

9.  Pinocytosis in fibroblasts. Quantitative studies in vitro.

Authors:  R M Steinman; J M Silver; Z A Cohn
Journal:  J Cell Biol       Date:  1974-12       Impact factor: 10.539

10.  Binding of antigen by immunocytes. I. Effect of ligand valence on binding affinity of MOPC 315 cells for DNP conjugates.

Authors:  J C Bystryn; G W Siskind; J W Uhr
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

  10 in total
  5 in total

1.  Profound specific suppression by antigen of persistent IgM, IgG, and IgE antibody production.

Authors:  H M Dintzis; R Z Dintzis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

2.  Single-step grafting of aminooxy-peptides to hyaluronan: a simple approach to multifunctional therapeutics for experimental autoimmune encephalomyelitis.

Authors:  Joshua Sestak; Meagan Mullins; Laura Northrup; Sharadvi Thati; M Laird Forrest; Teruna J Siahaan; Cory Berkland
Journal:  J Control Release       Date:  2013-03-27       Impact factor: 9.776

Review 3.  Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases.

Authors:  Mario E G Moral; Teruna J Siahaan
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

4.  Induction of tolerance by administration of hapten-immunoglobulin conjugates is associated with decreased IL-2 and IL-4 production.

Authors:  V Dumas; W Ptak; M Demarchez; J H Saurat; Y Borel; C Hauser
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

5.  Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness.

Authors:  J P Abastado; Y C Lone; A Casrouge; G Boulot; P Kourilsky
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.